EUVIMEDEUVIMED entdecken
Crossref

LC–MS/MS‐Based Monitoring of Pregabalin and Gabapentin Reveals Marked Pharmacokinetic Variability and Limited Exposure–Response Relationships in Neuropathic Pain Patients

Duygu Eryavuz Onmaz iD, Fettah Eren iD, Kadir Gulsen, Firdevs Sak, Mohammad Ahmad Bik, Rabia Coban, Sedat Abusoglu, Ali Unlu

Biomedical Chromatography · 2026-08 · 40 (8)

DOI: 10.1002/bmc.70539 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 02.07.2026. Verfasst von Duygu Eryavuz Onmaz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Bandirma Onyedi Eylul University Faculty of Medicine, Bandirma, Turkey. Hauptthemen laut MEDLINE: Pregabalin, Tandem Mass Spectrometry, Neuralgia, gamma-Aminobutyric Acid. Die Arbeit nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to develop and validate a liquid chromatography–tandem mass spectrometry (LC–MS/MS) assay for the simultaneous quantification of pregabalin (PGB) and gabapentin (GBP) and to explore real‐world pharmacokinetic variability. A bioanalytical LC–MS/MS method was validated using serum samples prepared by acetonitrile protein precipitation. Chromatographic separation was achieved on a C18 column with gradient elution and positive electrospray ionization. The validated method was applied to serum samples obtained from 65 patients, and associations between serum drug concentrations and clinical measures were evaluated. The assay demonstrated excellent linearity ( R ² > 0.998), acceptable precision and accuracy, recovery ranging from 96.9% to 101.5%, and matrix effects below 7%. Considerable inter‐individual variability in serum concentrations was observed (PGB: median 700 ng/mL [IQR: 500–1000]; GBP: median 4500 ng/mL [IQR: 3200–5700]). No significant dose–concentration relationships were identified (PGB: ρ = 0.03; GBP: ρ = −0.08), and no significant associations were observed between serum concentrations and the clinical outcome measures assessed. In contrast, both drugs showed moderate inverse correlations with post‐dose sampling interval (PGB: ρ = −0.46; GBP: ρ = −0.45). These findings indicate substantial pharmacokinetic variability of gabapentinoids under routine clinical conditions. Although no clear dose–concentration or exposure–response relationships were identified in this cohort, interpretation should be made cautiously because of non‐standardized sampling conditions and the relatively narrow range of renal function among participants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PregabalinTandem Mass SpectrometryNeuralgiagamma-Aminobutyric AcidCyclohexanecarboxylic AcidsLiquid Chromatography-Mass SpectrometryAminesAnalgesicsHumansGabapentinReproducibility of ResultsFemaleMaleLinear ModelsMiddle AgedAgedDrug MonitoringAdultSensitivity and Specificity

Stichwörter der Autor:innen

LC–MS/MSbioanalytical method validationgabapentinpregabalintherapeutic drug monitoring

Substanzen

GabapentinPregabalingamma-Aminobutyric AcidCyclohexanecarboxylic AcidsAminesAnalgesics

Autor:innen und Institutionen

  • Department of Biochemistry, Bandirma Onyedi Eylul University Faculty of Medicine, Bandirma, Turkey.
  • Department of Neurology, Selcuk University Faculty of Medicine, Konya, Turkey.
  • Department of Biochemistry, Selcuk University Faculty of Medicine, Konya, Turkey.

ORCID-Profile: Duygu Eryavuz Onmaz, Fettah Eren

Zitieren

APA

Eryavuz Onmaz, D., Eren, F., Gulsen, K., Sak, F., Bik, M. A., Coban, R., Abusoglu, S., & Unlu, A. (2026). LC–MS/MS‐Based Monitoring of Pregabalin and Gabapentin Reveals Marked Pharmacokinetic Variability and Limited Exposure–Response Relationships in Neuropathic Pain Patients. Biomedical Chromatography, 40(8). https://doi.org/10.1002/bmc.70539

Vancouver

Eryavuz Onmaz D, Eren F, Gulsen K, Sak F, Bik MA, Coban R, et al. LC–MS/MS‐Based Monitoring of Pregabalin and Gabapentin Reveals Marked Pharmacokinetic Variability and Limited Exposure–Response Relationships in Neuropathic Pain Patients. Biomedical Chromatography. 2026;40(8). doi:10.1002/bmc.70539

BibTeX
@article{EryavuzOnmaz2026,
  author = {Eryavuz Onmaz, Duygu and Eren, Fettah and Gulsen, Kadir and Sak, Firdevs and Bik, Mohammad Ahmad and Coban, Rabia and Abusoglu, Sedat and Unlu, Ali},
  title = {LC–MS/MS‐Based Monitoring of Pregabalin and Gabapentin Reveals Marked Pharmacokinetic Variability and Limited Exposure–Response Relationships in Neuropathic Pain Patients},
  journal = {Biomedical Chromatography},
  year = {2026},
  volume = {40},
  number = {8},
  doi = {10.1002/bmc.70539}
}
Kostenlos starten →